发明名称 COMPOUNDS
摘要 COMPOUNDS Compounds of general formula I: (I) wherein: R1 represents a hydrogen atom or a C1-C6 alkyl, C1-C6 alkenyl, phenyl, phenyl(C1-C6)alkyl, C1-C6 alkylthiomethyl, phenylthiomethyl, substituted phenylthiomethyl, phenyl(C1-C6)alkylthiomethyl or heterocyclylthiomethyl group; or R1 represents -SRx wherein Rx represents a group ; R2 represents a hydrogen atom or a C1-C6 alkyl, C1-C6 alkenyl, phenyl(C1-C6)alkyl, cycloalkyl(C1C6)alkyl, or cycloalkenyl(C1-C6)alkyl; R3 represents an amino acid residue with R or S stereochemistry or a C1-C6 alkyl, benzyl, (C1C6)alkoxybenzyl or benzyloxy(C1-C6)alkyl group; R4 represents a hydrogen atom or a methyl group; n is an integer from 1 to 6; and A represents the group -NH2, a substituted acyclic amine or a heterocyclic base; or a salt and/or N-oxide and/or (where the compound is a thio-compound) a sulphoxide or sulphone thereof have collagenase inhibition activity and are useful in the management of disease involving tissue degradation and/or the promotion of wound healing. Diseases involving tissue degradation include arthropathy (particularly rheumatoid arthritis), inflammation, dermatological diseases, bone resorption diseases and tumour invasion.
申请公布号 CA2003719(A1) 申请公布日期 1990.05.23
申请号 CA19892003719 申请日期 1989.11.23
申请人 BRITISH BIO-TECHNOLOGY LIMITED 发明人 DAVIDSON, ALAN H.;DICKENS, JON P.;CRIMMIN, MICHAEL J.
分类号 C07D295/12;A61K31/16;A61K31/165;A61K31/40;A61K31/415;A61K31/4184;A61K31/44;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/4418;A61K31/445;A61K31/454;A61P17/00;A61P29/00;A61P35/00;A61P43/00;C07C237/22;C07C259/06;C07C317/44;C07C323/60;C07D207/09;C07D207/32;C07D207/335;C07D211/14;C07D213/40;C07D233/60;C07D233/61;C07D235/14;C07D295/13;C07D521/00;(IPC1-7):C07D207/337;C07D295/15;C07D213/56 主分类号 C07D295/12
代理机构 代理人
主权项
地址
您可能感兴趣的专利